Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115927) titled 'A Study of Ivonescimab Plus Neoadjuvant Chemotherapy Followed by Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer' on Jan. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Women's Hospital, Zhejiang University School of Medicine
Condition:
Patients with high-risk locally advanced cervical cancer who have not received prior anti-tumor therapy, with histological types including squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-10
Target Sample Size: Ivonescimab pl...